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AbsTrACT
background Exercise-induced laryngeal obstruction 
(EILO) is common in athletes and presents with dyspnoea, 
chest tightness, inspiratory stridor and sometimes panic 
reactions. The evidence for conservative treatment is 
weak, but case reports suggest effects from inspiratory 
muscle training (IMT). We aimed to explore effects from 
IMT used in athletes with EILO.
Method Twenty-eight athletes, mean age 16.4 
years, diagnosed with EILO at our clinic, participated 
in a 6-week treatment programme, using a resistive 
flow-dependent IMT device (Respifit S). Four athletes 
competed at international level, 13 at national and 11 
at regional levels. Video-recorded continuous transnasal 
flexible laryngoscopy was performed from rest to peak 
exercise (continuous laryngoscopy exercise (CLE) test) 
and scored before and 2–4 weeks after the training 
period. Ergospirometric variables were obtained from this 
CLE set-up. Lung function was measured according to 
guidelines. Symptom scores and demographic variables 
were obtained from a questionnaire.
results After the treatment period, symptoms had 
decreased in 22/28 (79%) participants. Mean overall CLE 
score had improved after treatment (p<0.001), with the 
scores becoming normal in five athletes but worse in two. 
Most of the improvement was explained by changes at the 
glottic laryngeal level (p=0.009). Ergospirometric variables 
revealed significantly higher peak minute ventilation 
explained by higher tidal volumes and were otherwise 
unchanged.
Conclusion This explorative study underlines the 
heterogeneous treatment response of EILO and suggests 
that IMT may become an efficient conservative treatment 
tool in subgroups, possibly contributing to better control 
of the vocal folds. The signals from this study should be 
tested in future controlled interventional studies.
InTroduCTIon
Exercise-induced inspiratory symptoms 
(EIIS) are common in young athletes,1 and 
primarily characterised by prolonged and/
or noisy inspiration and shortness of breath.2 
EIIS usually occurs during vigorous exercise 
when the ventilation requirement is high 
and resolves spontaneously shortly after 
termination of the exertion. EIIS are most 
often related to obstruction of the larynx, 
involving either supraglottic laryngeal struc-
tures and/or the vocal folds, and should 
then be labelled exercise-induced laryngeal 
obstruction (EILO).3 4 The prevalence of 
EILO in unselected young Scandinavian 
populations has been reported to be 5.7% 
and 7.5%,5 6 and as high as 35.2% in athletes.1
Despite widely different pathophysiology, 
EILO is often confused with exercise-in-
duced bronchoconstriction (EIB) which is an 
What are the new findings?
 ► This explorative study of athletes with exercise-in-
duced laryngeal obstruction (EILO) suggests that 
respiratory symptoms and scores from continuous 
laryngoscopy exercise (CLE) tests can improve after 
a treatment period with inspiratory muscle training 
(IMT).
 ► The IMT treatment period primarily seemed to im-
prove the glottic CLE subscores.
 ► IMT may be a tool to treat subgroups of athletes with 
EILO; however, controlled trials are needed to estab-
lish the scientific evidence.
How might it impact on clinical practice in the 
future?
 ► The findings further substantiate that larynx should 
be visualised from rest to peak exertion in all ath-
letes who suffer from symptoms suggesting EILO.
 ► The findings highlight the heterogeneity of EILO, and 
that future treatment is likely to be individually tai-
lored and based on a more comprehensive pheno-
typing than today.
 ► The study provides data that can serve as basis for 
setting up controlled studies on IMT used to treat 
EILO in athletes.
 ► Providing the findings are verified in future controlled 
studies, IMT may become a conservative treatment 
tool for subgroups of EILO, possibly contributing to 
better control of the vocal fold movements.
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unfortunate situation that sometimes leads to prescrip-
tion of high doses of asthma medication.1 2 6–9 The 
literature highlights that EILO should be diagnosed by 
means of objective methodology, visualising the laryngeal 
structures from rest to peak exertion.3 In most cases, the 
obstruction seems to originate in supraglottic structures 
(including the epiglottis) during the inspiratory phase 
of the breathing cycles, increasing as the ventilatory 
requirements increase with increasing exercise load,9 10 
before glottic structures become involved, seemingly as 
a secondary phenomenon; however, this is not always 
so.2 11 12 This observed heterogeneity in the laryngeal 
findings suggests that one treatment modality is unlikely 
to work in all phenotypes of EILO.
So far, the evidence base for EILO treatment has been 
weak, generally consisting of small studies or single case 
reports conducted in poorly defined patient groups 
(EILO phenotypes), often with vaguely defined outcome 
measures.4 Historically, there are case reports suggesting 
effects from inspiratory muscle training (IMT).12–15 
However, the mechanisms involved are unclear, for 
example, we do not know if IMT would influence glottic 
and supraglottic EILO in different ways, information 
that would aid the planning of further studies of this 
treatment. Thus, aiming to expand our knowledge on 
non-invasive treatment tools for EILO, we embarked 
on this explorative study, addressing effects from IMT 
offered to motivated athletes consecutively presenting at 
our EILO clinic, irrespective of phenotype.
MeTHods
Participants and study design
Within an explorative study design, all athletes consec-
utively referred for work-up of EIIS and diagnosed with 
EILO at the outpatient clinic at the Pediatric Department 
of Haukeland University Hospital in Western Norway 
between May 2012 and May 2014 were offered a struc-
tured treatment period with IMT, providing a device 
was available (ie, convenience-based inclusion within a 
given time frame). The inclusion criteria required that 
the severity scores of EILO obtained during a continuous 
laryngoscopy exercise (CLE) test16 were graded as two 
or more, either at the supraglottic level or at the vocal 
folds (ie, the glottic level)17 (regarding CLE scores, see 
figure 1). Moreover, there should be no evidence that EIB 
could explain the patient’s symptoms. Asthma per se was 
not an exclusion criterion, but in cases where asthma was 
present or suspected, EIB was excluded as cause of symp-
toms by performing a standardised test as described by 
Carlsen et al, either at our institution or by the referring 
institution.18 CLE scores, lung function and ergospirom-
etry data were collected before and 2–4 weeks after the 
IMT treatment period, as were symptom scores obtained 
using a standardised questionnaire that also served to 
obtain demographic background variables. All athletes 
answered the question “When you are physically active, how 
much are you bothered by your breathing difficulties?”, using 
a numeric rating scale from 1 to 5 (1=nothing, 2=a bit, 
3=pretty much, 4=a lot and 5=disabling). The study was 
approved by the Committee on Medical Research Ethics 
of Western Norway (REK number 2009/2111), and 
informed written consent was obtained from the partic-
ipants. 
CLe test
An integrated set-up for continuous video-recorded 
laryngoscopy throughout a maximal cardiopulmonary 
exercise test, coupled with video recordings of the upper 
part of the body and sound recordings, was applied as 
previously described.16
A transnasal flexible fiberoptic laryngoscope (Olympus 
ENF-P3, Tokyo, Japan), diameter 3.5 mm, was introduced 
after applying a decongestive nasal spray (Rhinox) and 
local anaesthesia (Xylocaine), and secured in a posi-
tion allowing for a good view of the laryngeal entrance, 
including both supraglottic structures and the vocal folds. 
Continuous video recordings from the laryngoscope, a 
film of the upper part of the body and breath sounds were 
obtained simultaneously throughout the exercise test 
and stored in one single file for later evaluation. Laryn-
geal movements were scored as described previously17; at 
moderate (ie, when the test person changed from walking 
to running) and at maximal exercise intensity at glottic 
(labelled A and C, respectively) and supraglottic (labelled 
B and D, respectively) levels, and additionally a total sum 
score labelled E (figure 1). A CLE subscore of 1 (glottic 
or supraglottic) was regarded as normal.2 All assessments 
were done by two experienced raters (HHC and ODR) 
who were exposed to anonymised video recordings from 
all participants, blinded to the circumstances under 
which the video had been obtained, that is, if the video 
had been obtained before or after the treatment period. 
An uninvolved photographer presented the two films 
from each participant in random order. Disagreements 
were solved by consensus. Clinical symptoms during the 
CLE test were recorded in a questionnaire.
Pulmonary function and exercise test
Spirometry was performed with a Vmax 22 (Sensor-
Medics, Yorba Linda, California, USA) according to 
guidelines,19 recording FVC, FEV
1
 and forced expiratory 
flow at 50% of FVC (FEF
50%
), and reported as percentages 
of predicted.20 Forced inspiratory volume in first second 
(FIV
1
) and forced inspiratory flow at 50% (FIF
50%
) of 









 were calculated and classi-
fied as abnormal if exceeding 1.5.8 The configuration 
of the flow-volume loops (FVL) was classified as normal 
or abnormal by an experienced respiratory physiologist 
(ODR), based on flattening or truncation of the inspira-
tory limbs.21 The patients ran on a treadmill (Woodway 
ELG 70, Weil am Rhein, Germany) using a computerised 
and modified Bruce protocol,22 increasing speed and/or 
elevation every minute, aiming to reach maximum exer-
cise capacity after 6–12 min. Variables of gas exchange 
were measured breath by breath using a facemask (Hans 
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Figure 1 Grading system according to Maat et al17 reproduced with permission.
Rudolph, Kansas City, Missouri, USA) connected to a 
Jaeger Oxycon Pro Cardiopulmonary Exercise testing 
system (Viasys Health Care, Yorba Linda, California, 
USA). The test was considered successful if the patient 
continued until exhaustion, preferably supported by 
a plateau in oxygen consumption and/or the heart 
rate response, or until stopped by respiratory distress. 
Duration and distance on treadmill running were 
recorded.
Inspiratory muscle training
Respifit S (Biegler GmbH, Mauerbach, Austria) was 
used to measure the maximal inspiratory mouth pres-
sure (PI
max
), using the best value of 10 according to 
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Table 1 Characteristics of 28 included athletes 
consecutively referred for work-up of EIIS and diagnosed 
with EILO at the outpatient clinic at the Pediatric 
Department of Haukeland University Hospital in Bergen, 
Norway between May 2012 and May 2014 who were offered 
a structured treatment period with IMT
Variable N=28
Category Statistic
Female, n (%) 24 (85.7)
Age in years, mean (SD) 16.4 (2.8)
Height in cm, mean (SD) 169.4 (8.4)
Weight in kg, mean (SD) 61.6 (10.9)
Type of sports, n
  Soccer 6
  Handball 6
  Cross-country skiing 4
  Biathlon 4
  Athletics 2
  Cycling 2
  Swimming 2
  Running 1
  Kayaking 1
Competition level, n
  International 4
  National 13
  National regional 11
Level of laryngeal obstruction*
  Supraglottic>glottic 7/28
  Glottic>supraglottic 2/28
  Supraglottic=glottic 19/28
  Solely glottic 0/28
*At maximum exercise, before IMT.
EIIS, exercise-induced inspiratory symptom; EILO, exercise-
induced laryngeal obstruction; IMT, inspiratory muscle training.
guidelines23 in order to provide exact settings of the 
resistance during the IMT sessions. The same device was 
used for the 6-week training sessions. To promote correct 
breathing technique, the participants were instructed to 
inhale using the diaphragm and to minimise movements 
of the shoulders in the cranial direction. Two modes of 
inspiratory muscle training were tested in accordance 
with the manual supplied by the manufacturer, that is, 
(1) inspiratory muscle strength training (IMST) with the 
resistance set to produce mouth pressures ≥80% of PI
max
 
and (2) moderate resistance or inspiratory muscle endur-
ance training (IMET) with the resistance set at 60%–80% 
of PI
max
. In the IMST sessions, subjects performed five 
maximal inhalations repeated three times, separated 
by a 1 min break. In the IMET sessions, subjects were 
instructed to breathe in and out 12–16 times for 1 min. 
The frequency and power were guided by an animation 
program ensuring correct use of the device, and data 
from each training session were stored by a memory 
card measuring treatment compliance. The participants 
trained every day, in cycles of 2 days with IMET followed 
by 1 day of IMST, for a total of 6 weeks.
statistical methods
This was a descriptive study, with main outcomes being 
the CLE scores and symptom scores obtained before 
versus after the IMT treatment period, compared using 
Gosset’s paired sample t-test.24 Means, SD, 95% CIs and 
ranges were calculated, as appropriate. The CLE scores 
are by nature ordinal and categorical, ranging from 0 to 
3. Due to the few number of categories, the data were 
reported as mean values and mean differences with 95% 
CI, as this is considered to provide more information 
than medians and IQRs.25 Mixed linear model regression 
including interaction terms were applied to address if 
CLE-score changes (before vs after the treatment period) 
differed when obtained at moderate versus maximal 
exercise intensity and at the glottic versus supraglottic 
laryngeal level.26
All analyses were performed with SPSS V.24.
resuLTs
Fifty-one eligible athletes presented to our clinic during 
the inclusion period, of whom 30 (59%) were included 
within the convenience-based sampling structure of the 
study. Two included athletes had to be excluded due to 
incomplete data sets. The age range of the remaining 28 
was 12–25 years (mean 16.4), 4 males and 24 females. 
Four athletes were competing at international level, 13 at 
a national level and 11 at a regional level, and they were 
engaged in various endurance sports (table 1). Lung 
function was normal in all.
subjective scores
After the IMT treatment period, 22/28 (79%) responded 
yes to a question if they felt their EILO problem had 
improved during the treatment period. Mean (SD) 
ratings obtained before versus after the IMT treatment 
period to the question “how much are you bothered by your 
breathing difficulties” were 3.63 (0.79) versus 2.93 (1.07), 
respectively (p<0.001). After the IMT treatment period, 
12/28 (43%) athletes responded nothing or a bit to this 
question, whereas one reported that symptoms had 
increased.
Laryngeal findings during exercise (CLe scores)
At diagnosis, before the treatment period at maximum 
exercise, none had a solely glottic obstruction, 7/28 had 
supraglottic score exceeding the glottic score, 2/28 had 
glottic score exceeding the supraglottic score and 19/28 
had similar supraglottic and glottic score (table 1). After 
the IMT treatment period, 5/28 (18%) athletes had no 
signs of laryngeal obstruction, presenting with CLE sum 
scores 0 or 1. In 23/28 (82%) athletes, the CLE sum scores 
had improved, eight of whom had a decrease in CLE sum 
score of two or more, whereas 3/28 had the same CLE 
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Table 2 Mean CLE score differences as obtained at glottic and supraglottic laryngeal levels at moderate and maximal 
exercise intensity before versus after the IMT treatment period in 28 included athletes consecutively referred for work-up of 
EIIS and diagnosed with EILO at the outpatient clinic at the Pediatric Department of Haukeland University Hospital in Bergen, 
Norway between May 2012 and May 2014 as estimated from mixed model linear regression analysis
Exercise intensity Glottic/supraglottic
CLE score 
differences SE 95% CI F-test p value*
Moderate Glottic 0.11 0.13 −0.16 to 0.37 0.426
Moderate Supraglottic 0.07 0.13 −0.19 to 0.34 0.596
Maximal Glottic 0.93 0.13 0.66 to 1.19 <0.001
Maximal Supraglottic 0.18 0.13 −0.09 to 0.44 0.186
Overall 0.32 0.07 0.19 to 0.54 <0.001
*P value for three-way interaction: 0.009.
CLE, continuous laryngoscopy exercise; EIIS, exercise-induced inspiratory symptom; EILO, exercise-induced laryngeal obstruction; IMT, 
inspiratory muscle training.
Figure 2 CLE scores before and after treatment with IMT 
of 28 athletes consecutively referred for work-up of EIIS and 
diagnosed with EILO at the outpatient clinic at the Pediatric 
Department of Haukeland University Hospital in Bergen, 
Norway between May 2012 and May 2014. Dots represent 
mean values, and vertical lines represent 95% confidence 
intervals. CLE-scores, Continuous laryngoscopy exercise 
test (0-3); IMT, Inspiratory Muscle training; EIIS, Exercise 
induced inspiratory symptoms; EILO, Exercise induced 
laryngeal obstruction.
sum scores before and after the treatment period. In 
two athletes, the CLE sum score had increased, of whom 
one was judged by both raters as a classical supraglottic 
phenotype of EILO and the other as a typical glottic 
EILO phenotype, characterised by anxiety and panic.
The pre-treatment versus the post-treatment differ-
ences in the CLE scores are given in table 2. A significant 
difference was observed only at maximal exercise inten-
sity at the glottic laryngeal level. In the mixed model 
linear regression of CLE scores obtained pre-treatment 
versus post-treatment at moderate versus maximal 
exercise intensity at the glottic versus the supraglottic 
laryngeal level, the three-way interaction was found to be 
highly significant (F-test p=0.009) (table 2), confirming 
that CLE-score changes at maximal exercise intensity at 
the glottic laryngeal level explained most of the overall 
effect. The mean CLE scores with 95% CIs are presented 
in figure 2.
spirometric and cardiopulmonary outcomes
The shape of the inspiratory limb of the flow-volume loop 
could be assessed in 25/28 athletes. The configuration 







/FIV ratios exceeding 1.5 were not seen 




 ratio was significantly lower 
after versus before the IMT treatment period (table 3).
The distance completed, the time spent running on 
the treadmill, the obtained peak VO
2
 and the maximal 
heart rate did not differ before versus after the IMT 
treatment period. The minute ventilation (VE) and the 
tidal volume (Vt) increased significantly during the IMT 
training period, and the breathing rate was numerically 
(although not significantly) slightly reduced (table 3).
dIsCussIon
After a 6-week training period with IMT, most partic-
ipating athletes (22/28 or 79%) reported subjective 
improvement. The CLE scores improved in 23 partici-
pants (82%), had become normal in five (18%) but worse 
in two (7%). Improvements were linked to a change at 
the glottic laryngeal level at peak exercise. Ergospiro-
metric variables revealed significantly higher peak VE 
explained by higher Vt but were otherwise unchanged 
(eg, no changes in peak VO
2
). The findings suggest 
that controlled studies should be incited, hypothesising 
that IMT can become an efficient treatment modality 
in subgroups of EILO, with particular focus on studying 
patients with glottic EILO.
strengths and weaknesses of the study
The major strength of this study was the application of 
the best available and also a verifiable outcome measure, 
that is, CLE scores obtained before and after the IMT 
treatment period. CLE scores are based on endoscopic 
visual evaluation of laryngeal structures from rest to 
peak exercise, which is the gold standard for diagnosing 
EILO.3 CLE testing has been successfully applied in 
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Table 3 Physiological outcomes in 28 included athletes consecutively referred for work-up of EIIS and diagnosed with EILO 
at the outpatient clinic at the Pediatric Department of Haukeland University Hospital in Bergen, Norway between May 2012 
and May 2014
Pre-IMT n=28 Post-IMT n=28 P value
PEF % predicted 105.6 (13.6) 108.0 (13.0) 0.020
FVC % predicted 111.9 (11.4) 112.2 (12.1) 0.685
FEV
1










0.98 (0.2) 0.90 (0.2) 0.017
Distance on treadmill (m) 778.2 (159.8) 800.5 (174.7) 0.136
Time on treadmill (min) 10.9 (1.28) 11.0 (1.36) 0.248
Heart rate max (bpm) 187 (10) 187 (8) 0.853
VO
2
 peak (mL/min) 3143 (654) 3135 (644) 0.856
VO
2
 peak (mL/min/kg) 51.6 (9.2) 51.1 (8.9) 0.415
VE (L/min) 105.1 (26.0) 109.6 (24.2) 0.036
Breathing reserve (%) 17.5 (13.0) 14.2 (11.6) 0.057
Breathing rate (breaths/min) 50 (9) 48 (7) 0.224
Vt (L/breath) 2.14 (0.50) 2.31 (0.51) 0.003
EIIS, exercise-induced inspiratory symptom; EILO, exercise-induced laryngeal obstruction; FEF50, forced expiratory flow at 50%; FEV1, 
forced expiratory volume in first second; FIF50, forced inspiratory flow at 50%; FIV1, forced inspiratory volume in first second; IMT, 
inspiratory muscle training; PEF, peak expiratory flow; VE, Minute ventilation; VO2 peak, peak oxygen uptake; Vt, Tidal volume.
numerous recent studies in this field of respiratory medi-
cine.1 2 4–6 11 17 27–35 Studies addressing the validity and 
reliability of the CLE scoring system have reached some-
what variable conclusions.17 36 37 It nevertheless seems 
reasonable to conclude that experience is a factor that 
influences these issues. In this study, two highly experi-
enced raters, both having assessed CLE recordings form 
approximately 2000 patients, performed all scoring 
procedures according to a strict system designed to 
handle the expressed concerns to the extent possible. 
Previous studies addressing effects from treatments of 
EILO have mostly relied on symptom reports. As symp-
toms reported by patients with exercise-related breathing 
problems have been found inadequate as a diagnostic tool 
in several studies,1 2 5 6 11 38 39 a similar inadequacy seems 
likely to expect also in a context addressing effects from 
treatments. Thus, in this respect, this study represents 
an improvement. The convenience-based sampling 
process with relatively few participants with a strong 
preponderance of young female participants are obvious 
weaknesses. There are no published well-designed epide-
miological studies of EILO in athletes; however, most, 
but not all,6 clinical studies report age and sex distribu-
tions similar to this present study.2 5 40 Finally, the lack of 
a control group or some sort of ‘sham treatment’ clearly 
weakens the conclusions, as this leaves the study open 
for unknown effects from participants becoming famil-
iarised with the CLE procedure, and thus might have 
become more relaxed at the second test performed after 
the treatment period. Having in mind the explorative 
study design, these weaknesses should incite designing 
properly controlled studies of IMT in EILO, focusing 
particularly on the glottic components.
Inspiratory muscle training
The theoretical basis for testing effects from IMT in 
patients suffering from EILO is based on the phasic 
relationship that exists between the diaphragm and the 
posterior cricoarytenoid (PCA) muscle, which is the 
main abductor of the vocal folds.41 42 Signalled via the 
vagal nerve, the PCA muscle contracts slightly before 
the diaphragm, abducting the larynx before air starts 
entering the airways.43 By using MRI, How et al demon-
strated that also upper airway dilator muscles, external 
muscles as genioglossus and geniohyoid, are activated 
in response to IMT, providing evidence for IMT being 
able to condition upper airway muscles.44 We have previ-
ously reported how various IMT modes influenced the 
larynx in healthy subjects, with lower resistance loads 
seemingly targeting abduction better than higher loads30 
suggesting that IMT applied as low-intensity endurance 
training (IMET) would be better suited as treatment for 
EILO than IMST. Since this present study was the first 
to apply IMT in a systematic way in patients with EILO, 
we nonetheless chose the training program prescribed 
by the manual provided by the manufacturer. Previous 
studies on other groups of patients have tended to use 
resistance load set from 40% to 90% of PI
max
.13 14 45 46 We 
need a randomised control study to solve this issue with 
IMST versus IMET.
The goal of any treatment for EILO is to achieve a 
more effective and better controlled laryngeal abduction 
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during exercise, and thereby facilitate air flowing through 
the laryngeal inlet at an increasing speed without causing 
an undue increase of resistance. Our study showed a 
significant improvement in minute ventilation, neces-
sarily reflecting also increased airflow through the 
larynx. This outcome was related to a significant increase 
in Vt and a tendency for lower breath rates (not signif-
icant); however, it was somewhat inconsistent from test 
to test and therefore difficult to interpret physiologically. 
Peak VO
2
 did not differ, suggesting a relieved (improved) 
breathing pattern at peak exercise. Regrettably, we do not 
have access to blood gases to properly substantiate such 
potential ventilatory effects. Resting spirometry obtained 
before and after the treatment period confirmed low 





 ratio after treatment suggests 
that inspiratory resistance was reduced, also at rest.
CLe scores as outcome measure in eILo treatment studies
The evidence base for effects of different treatment 
options for EILO is limited, and a general lack of veri-
fiable outcome measures complicates interpretations of 
previous studies. PI
max
 is the most commonly used IMT 
outcome measure, but in patients with EILO, PI
max
 seems 
irrelevant since the treatment targets coordination of 
inspiratory laryngeal movements more than the strength 
of the diaphragm.30 Reports of subjective improve-
ments certainly provide information that is important, 
but has serious sources of error,48 and do not enhance 
our causal understanding. The use of verifiable visual 
laryngeal outcome measures such as CLE scores16 17 
can provide information that serve to understand this 
prevalent condition better, for example, contribute to 
distinguishing psychological from organic breathing 
problems, and to understand what structures incite and 
perpetuate the pathology of a malfunctioning larynx in 
a patient with EILO. Studies have questioned inter-rater 
reliability of CLE scores,37 and measures should be taken 
to ensure a high level of experience among raters, with 
disagreements solved by consensus, as in this study. We 
have reported highly divergent responses to IMT in a 
previous case report,12 further substantiated in this study 
with two participants deteriorating after the treatment 
period. Effects seemed linked to changes at the glottic 
level during maximum intensity suggesting that IMT may 
be most likely to improve EILO where glottic structures 
are most heavily involved. Moreover, one should probably 
be careful applying IMT in patients with a predominant 
supraglottic EILO. However, these are data revealed in 
an uncontrolled and explorative study, and we need 
well-designed in-depth controlled studies to investigate 
these signals further.
ConCLusIon
This study underlines the heterogeneity of EILO and 
suggests that future treatment is likely to be individ-
ually tailored and based on a more comprehensive 
phenotyping than today. The study suggests that IMT 
may become an efficient conservative treatment tool in 
subgroups of EILO, and that IMT might contribute to 
the patient achieving a better control of particularly the 
vocal fold movements. The signals from this explorative 
study should be tested in future controlled interventional 
studies. The cliche ‘more studies are needed’ certainly 
applies to this large and under-studied group of patients.
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